Savara (SVRA) EBT (2010 - 2026)
Savara's (SVRA) quarterly EBT came in at -$39.9 million in Q1 2026, down 49.61% year-on-year from -$79.1 million in Q1 2025, and down 28.83% on a QoQ basis from -$30.9 million in Q4 2025.
Savara (SVRA) EBT (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of EBT data on file, last reported at -$39.9 million in Q1 2026.
- On a quarterly basis, EBT fell 49.61% year-over-year to -$39.9 million in Q1 2026; TTM through Mar 2026 was -$132.5 million, a 22.48% decrease from a year earlier, with the FY2025 full-year figure at -$266.3 million, down 26.49% from the prior year.
- EBT for Q1 2026 stood at -$39.9 million, down from -$30.9 million in the prior quarter.
- Over the last five years, EBT for SVRA reached as high as -$8.6 million in Q1 2022 and fell as low as -$39.9 million in Q1 2026.
- Historically, EBT has averaged -$21.4 million across 5 years, with a median of -$20.3 million in 2024.
- Across the five-year window, EBT rose 21.11% in 2022 and slumped 85.18% in 2024, its largest moves.
- Year by year, EBT stood at -$11.3 million in 2022, then plunged by 58.9% to -$17.9 million in 2023, then sank by 78.31% to -$31.9 million in 2024, then increased by 3.15% to -$30.9 million in 2025, then slipped by 28.83% to -$39.9 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$39.9 million in Q1 2026, -$30.9 million in Q4 2025, and -$30.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | -39.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.85 Mn |
| Dec 31, 2025 | -30.94 Mn |
| Sep 30, 2025 | -30.13 Mn |
| Jun 30, 2025 | -31.56 Mn |
| Mar 31, 2025 | -26.64 Mn |
| Dec 31, 2024 | -31.94 Mn |
| Sep 30, 2024 | -26.06 Mn |
| Jun 30, 2024 | -23.52 Mn |
| Mar 31, 2024 | -20.35 Mn |
| Dec 31, 2023 | -17.91 Mn |
| Sep 30, 2023 | -18.44 Mn |
| Jun 30, 2023 | -12.70 Mn |
| Mar 31, 2023 | -12.56 Mn |
| Dec 31, 2022 | -11.27 Mn |
| Sep 30, 2022 | -10.96 Mn |
| Jun 30, 2022 | -9.90 Mn |
| Mar 31, 2022 | -8.62 Mn |
| Dec 31, 2021 | -11.18 Mn |
| Sep 30, 2021 | -10.08 Mn |
| Jun 30, 2021 | -10.54 Mn |